XML 20 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Statement of Changes In Shareholders’ Deficit - 8 months ended Dec. 31, 2025 - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Apr. 30, 2025
Balance (in Shares) at Apr. 30, 2025 [1],[2]      
Class B ordinary shares issued to sponsor $ 863 24,137 25,000
Class B ordinary shares issued to sponsor (in Shares) 8,625,000 [1],[2]      
Sale of 779,000 Private Placement Units $ 78 7,789,922 7,790,000
Sale of 779,000 Private Placement Units (in Shares) 779,000 [1],[2]      
Fair value of Public Warrants at issuance 1,817,700 1,817,700
Allocated value of transaction costs to Class A non-redeemable shares (122,734) (122,734)
Forfeiture of founder shares $ (33) 33
Forfeiture of founder shares (in Shares) (325,000) [1],[2]      
Fair value of founder Shares assigned to directors 74,000 74,000
Accretion for Class A ordinary shares to redemption amount 9,583,058 9,866,891 19,449,949
Net income 2,625,175 2,625,175
Balance at Dec. 31, 2025 $ 78 $ 830 $ (7,241,716) $ (7,240,808)
Balance (in Shares) at Dec. 31, 2025 779,000 8,300,000 [1],[2]      
[1] Includes 1,125,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares (after taking into account the assignment of 40,000 founder shares to the directors) (Note 5).
[2] On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding. All share and per share amounts have been retroactively presented (Note 5).